ClinicalTrials.govpublic full text
Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging
nephrogenic fibrosing dermopathy, humans, gadodiamide, mri, renal insufficiency, drug-related adverse reactions, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869523
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.